Epilepsy, Tonic-Clonic Clinical Trial
Official title:
A Relative Bioavailability Study of Two Formulations of Topiramate 100 mg Coated Tablet in Healthy Male Volunteers, the Test Formulation Produced by Dr. Reddy's Laboratories Ltd. and the Reference Formulation (Topamax®) Marked by Janssen-Cilag Farmacêutica Ltda.
This study is prospective, open-label, randomized, crossover, single dose, with 02 treatments, 02 sequences and 02 periods. The volunteers received, in each period, the reference or the test formulation, according to the randomization list, under fasting conditions, in order to evaluate if the reference and test formulations are bioequivalent.
This study is prospective, open-label, randomized, crossover, single dose, with 02 treatments, 02 seuqences and 02 periods. The objective is to confirm if two formulations of topiramate 100 mg, coated tablet, are bioequivalent, after oral, single-dose administration under fasting conditions. The test product is topiramate 100 mg produced by Dr. Reddy's Laboratories Ltd. and the reference product is Topamax® marketed by Janssen-Cilag Farmacêutica Ltda. Twenty-eight healthy male volunteers were evaluated. The volunteers received, in each period, the test or the reference formulation, according to the randomization list. In each period, blood samples are collected in the following times: 00:00 (prior to the administration of medication); 00:20; 00:40; 01:00; 01:30; 02:00; 02:30; 03:00; 03:30; 04:00; 05:00; 06:00; 08:00; 12:00; 16:00; 20:00; 24:00; 48:00; 72:00; 96:00; 120:00; 144:00; 168:00; 192:00. The comparative bioavailability of the two formulations was evaluated based in statistical comparisons of relevant pharmacokinetic parameters, obtained from data of drug concentrations in blood. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04770337 -
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
|
N/A | |
Terminated |
NCT03831802 -
Embrace and Quality of Life
|
N/A | |
Withdrawn |
NCT04282681 -
XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)
|
||
Completed |
NCT00150787 -
Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.
|
Phase 3 | |
Completed |
NCT00231556 -
A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy
|
Phase 3 | |
Completed |
NCT03446664 -
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
|
N/A | |
Completed |
NCT00104416 -
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures
|
Phase 3 | |
Completed |
NCT00043901 -
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
|
Phase 4 | |
Completed |
NCT00150813 -
Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.
|
Phase 3 |